skip to content
Antifungals : From Genomics to Resistance and the Development of Novel Agents. Preview this item
ClosePreview this item
Checking...

Antifungals : From Genomics to Resistance and the Development of Novel Agents.

Author: Alix T Coste; Patrick Vandeputte
Publisher: Norfolk : Caister Academic Press, 2015.
Edition/Format:   eBook : Document : EnglishView all editions and formats
Summary:
Infections caused by pathogenic fungi are a significant global problem; a situation exacerbated by the limited availability of good antifungal options. Being eukaryotic organisms, these pathogens are phylogenetically much closer to the human host than bacterial pathogens. This sets serious limits to the range of exploitable fungal-specific drug targets. The advent of 'omics' and other high throughput technologies in  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Additional Physical Format: Print version:
Coste, Alix T.
Antifungals : From Genomics to Resistance and the Development of Novel Agents.
Portland : Caister Academic Press, ©2015
(OCoLC)885226356
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Alix T Coste; Patrick Vandeputte
ISBN: 9781910190029 1910190020
OCLC Number: 904518422
Notes: Introduction.
Description: 1 online resource (346 pages)
Contents: Contributors; Preface; 1: Molecular Mechanisms of Resistance of Candida spp. to Membrane-targeting Antifungals; Introduction; Azoles; Non-azole ergosterol biosynthesis inhibitors; Polyenes; Concluding remarks; 2: Point Mutations and Membrane-targeting Antifungal Resistance in Aspergillus fumigatus and Other Non-Candida Species; Introduction; Aspergillus fumigatus azole resistance in clinical settings; The molecular target of azoles, allylamines and polyenes: ergosterol and ergosterol biosynthesis pathway; Differences in ergosterol pathway between Aspergillus spp. and yeasts. Introduction to fungal biofilmsFungal biofilm infections of humans; Current standard of care for fungal biofilm infections; Mechanisms of fungal biofilm drug resistance; Challenges and strategies to developing therapeutics for fungal biofilm infections; 5: Drug Combinations as a Strategy to Potentiate Existing Antifungal Agents; Introduction; In vitro and in vivo combinations with known antifungal agents; In vitro and in vivo combinations of non-antifungals with known antifungal agents; Systematic drug combination screenings. Chemogenetic approaches in the exploration of drug interaction mechanismsConclusions; 6: Approaches to Detect Alternative Mechanisms of Resistance to Systemic Antifungals; Introduction; 'Omics' approaches; Mutants collections screening; Comparison with others species; Concluding remarks; 7: New Antifungal Discovery from Existing Chemical Compound Collections; Introduction; A new career for acetylsalicylic acid as an antifungal; Other non-traditional antimicrobial agents; Conclusion and future perspectives; 8: Exploring New Insights into Fungal Biology as Novel Antifungal Drug Targets.

Abstract:

Infections caused by pathogenic fungi are a significant global problem; a situation exacerbated by the limited availability of good antifungal options. Being eukaryotic organisms, these pathogens are phylogenetically much closer to the human host than bacterial pathogens. This sets serious limits to the range of exploitable fungal-specific drug targets. The advent of 'omics' and other high throughput technologies in recent years has revolutionized the field of antifungal research permitting researchers to quickly identify novel compounds and gain greater insights into drug resistance mechanism.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.

Similar Items

Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/904518422> # Antifungals : From Genomics to Resistance and the Development of Novel Agents.
    a schema:CreativeWork, schema:MediaObject, schema:Book ;
    library:oclcnum "904518422" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/enk> ;
    library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/2453857423#Place/norfolk> ; # Norfolk
    schema:about <http://experiment.worldcat.org/entity/work/data/2453857423#Topic/antifungal_agents> ; # Antifungal Agents
    schema:about <http://experiment.worldcat.org/entity/work/data/2453857423#Topic/antibiotics> ; # Antibiotics
    schema:about <http://experiment.worldcat.org/entity/work/data/2453857423#Topic/medical_pharmacology> ; # MEDICAL--Pharmacology
    schema:about <http://dewey.info/class/615.329/> ;
    schema:bookFormat schema:EBook ;
    schema:contributor <http://experiment.worldcat.org/entity/work/data/2453857423#Person/vandeputte_patrick> ; # Patrick Vandeputte
    schema:contributor <http://experiment.worldcat.org/entity/work/data/2453857423#Person/coste_alix_t> ; # Alix T. Coste
    schema:datePublished "2015" ;
    schema:description "Infections caused by pathogenic fungi are a significant global problem; a situation exacerbated by the limited availability of good antifungal options. Being eukaryotic organisms, these pathogens are phylogenetically much closer to the human host than bacterial pathogens. This sets serious limits to the range of exploitable fungal-specific drug targets. The advent of 'omics' and other high throughput technologies in recent years has revolutionized the field of antifungal research permitting researchers to quickly identify novel compounds and gain greater insights into drug resistance mechanism."@en ;
    schema:description "Contributors; Preface; 1: Molecular Mechanisms of Resistance of Candida spp. to Membrane-targeting Antifungals; Introduction; Azoles; Non-azole ergosterol biosynthesis inhibitors; Polyenes; Concluding remarks; 2: Point Mutations and Membrane-targeting Antifungal Resistance in Aspergillus fumigatus and Other Non-Candida Species; Introduction; Aspergillus fumigatus azole resistance in clinical settings; The molecular target of azoles, allylamines and polyenes: ergosterol and ergosterol biosynthesis pathway; Differences in ergosterol pathway between Aspergillus spp. and yeasts." ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/2453857423> ;
    schema:genre "Electronic books"@en ;
    schema:inLanguage "en" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/885226356> ;
    schema:name "Antifungals : From Genomics to Resistance and the Development of Novel Agents."@en ;
    schema:productID "904518422" ;
    schema:publication <http://www.worldcat.org/title/-/oclc/904518422#PublicationEvent/norfolk_caister_academic_press_2015> ;
    schema:publisher <http://experiment.worldcat.org/entity/work/data/2453857423#Agent/caister_academic_press> ; # Caister Academic Press
    schema:url <http://site.ebrary.com/id/11017449> ;
    schema:url <http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=948232> ;
    schema:workExample <http://worldcat.org/isbn/9781910190029> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/904518422> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/2453857423#Agent/caister_academic_press> # Caister Academic Press
    a bgn:Agent ;
    schema:name "Caister Academic Press" ;
    .

<http://experiment.worldcat.org/entity/work/data/2453857423#Person/coste_alix_t> # Alix T. Coste
    a schema:Person ;
    schema:familyName "Coste" ;
    schema:givenName "Alix T." ;
    schema:name "Alix T. Coste" ;
    .

<http://experiment.worldcat.org/entity/work/data/2453857423#Person/vandeputte_patrick> # Patrick Vandeputte
    a schema:Person ;
    schema:familyName "Vandeputte" ;
    schema:givenName "Patrick" ;
    schema:name "Patrick Vandeputte" ;
    .

<http://experiment.worldcat.org/entity/work/data/2453857423#Topic/antifungal_agents> # Antifungal Agents
    a schema:Intangible ;
    schema:name "Antifungal Agents"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/2453857423#Topic/medical_pharmacology> # MEDICAL--Pharmacology
    a schema:Intangible ;
    schema:name "MEDICAL--Pharmacology"@en ;
    .

<http://worldcat.org/isbn/9781910190029>
    a schema:ProductModel ;
    schema:isbn "1910190020" ;
    schema:isbn "9781910190029" ;
    .

<http://www.worldcat.org/oclc/885226356>
    a schema:CreativeWork ;
    rdfs:label "Antifungals : From Genomics to Resistance and the Development of Novel Agents." ;
    schema:description "Print version:" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/904518422> ; # Antifungals : From Genomics to Resistance and the Development of Novel Agents.
    .

<http://www.worldcat.org/title/-/oclc/904518422>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
    schema:about <http://www.worldcat.org/oclc/904518422> ; # Antifungals : From Genomics to Resistance and the Development of Novel Agents.
    schema:dateModified "2018-01-04" ;
    void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.